Dr. Ling Yin — Ph.D., Vice Dean, College of Life Science, Weifang Institute of Technology | Cancer Immunotherapy & AAV Gene Therapy Expert

Dr. Ling Yin

Ph.D. | Vice Dean, College of Life Science | Biological Scientist II

Weifang, China | International Collaborations (USA & China)

🎓 Professional Summary

Accomplished molecular biologist, cancer researcher, and academic leader with deep expertise in AAV-based gene therapy, cancer immunotherapy, precision oncology, multi-omics integration, and inflammation mechanisms (NLRP3 inflammasome). Transitioned from vegetable genetics & breeding (glucoraphanin/sulforaphane pathways) to translational biomedical research. Former Biological Scientist II and Postdoctoral Associate at University of Florida College of Medicine. Currently Vice Dean, College of Life Science, Weifang Institute of Technology. Prolific author of >30 refereed publications (2024–2026) in high-impact journals including Frontiers in Immunology, Molecular Therapy, Drug Discovery Today, and Global Translational Medicine. Active editorial board member, reviewer for top-tier journals, conference chair, and international judge (ISEF).

🎓 Education

  • Ph.D. in Vegetable Genetics and Breeding, South China Agricultural University, Guangzhou, China — Jun 2016
    Dissertation: Molecular Cloning, Expression Pattern And Characterization on Glucoraphanin Biosynthetic Related Genes in Chinese Kale (Brassica oleracea var. alboglabra Bailey)
  • M.S. in Vegetable Genetics and Breeding, Chinese Academy of Agricultural Sciences, Beijing, China — Jun 2012
    Thesis: Sensory Assess and Starch Properties Analysis of Pumpkin
  • B.A. in Plant Science and Engineering, Qingdao Agricultural University, Qingdao, China — Jun 2009

âś… Research Training & Expertise

  • Biostatistics & Bioinformatics 101 Statistical Software — University of Florida, Gainesville, FL (Sep 2019, 2021, 2023)
  • Editorial Leadership — Guest Editor / Associate Editor / Handling Editor for >20 international journals (Frontiers in Immunology, Global Translational Medicine, Molecular Therapy, iNew Medicine, etc.)

Core Expertise: AAV vector design & gene therapy, spatial transcriptomics, single-cell omics, sulforaphane precision medicine, ErbB/HER family targeting, NLRP3 inflammasome, cancer survivorship care, tissue clearing, immune checkpoint & ADC synergy.

Languages: English, Mandarin Chinese.

🔬 Research & Publications

Key Research Themes (2025–2026)
  • Sulforaphane in Cancer Precision Medicine: Biosynthetic origins to multiscale mechanisms and clinical translation (Front Immunol. 2025).
  • AAV Gene Therapy Revolution: Delivery systems, hepatocellular carcinoma suppression, and clinical breakthroughs.
  • Multi-Omics & AI-Driven Cancer Survivorship Care: Intelligent frameworks for next-generation oncology.
  • NLRP3 Inflammasome & ErbB/HER Family: From drug target to tumor microenvironment reprogramming.
  • Spatial Transcriptomics & Immune Crosstalk: Glioma blood-tumor barrier and microglia immunomodulation.
Selected High-Impact Publications
  • “Sulforaphane in cancer precision medicine: from biosynthetic origins to multiscale mechanisms and clinical translation”, Front Immunol. 2025. DOI: 10.3389/fimmu.2025.1702860.
  • “From Cancer Treatment Strategy to Cancer Survivorship Care: Advances in Multi-Omics and AI Integration”, Global Translational Medicine. 2026. DOI: 10.36922/GTM025470087.
  • “Bivalent Aptamer Assemblies: A Versatile Toolkit for Precision Targeting of B-Cell Malignancies”, Mol Ther Nucleic Acids. 2026. DOI: 10.1016/j.omtn.2026.102842.
  • “ErbB/HER Family in Cancer Immunology: Therapeutic Advances and Mechanisms”, Drug Discov Today. 2025. DOI: 10.1016/j.drudis.2025.104436.
  • “Revolution of AAV in Drug Discovery: From Delivery System to Clinical Application”, J Med Virol. 2025. DOI: 10.1002/jmv.70447.

🏅 Awards, Honors & Leadership Service

Awards & Academic Honours
  • Global Recognition Award — Feb 2026 & Dec 2024.
  • High-Caliber Talent of Hefei City — Jun 2025.
  • Outstanding Dissertation Award — South China Agricultural University, May 2017.
  • Outstanding Graduate Representative & Graduate Second Prize Awards — South China Agricultural University, 2015–2016.
  • Multiple Undergraduate Prize Awards — Qingdao Agricultural University, 2006–2008.
Leadership & Scholar Service
  • Vice Dean, College of Life Science, Weifang Institute of Technology (Mar 2026–present).
  • Grand Award Judge (ISEF) — Plant Sciences, Biomedical & Health Sciences, Microbiology, Animal Sciences (2018–2026, multiple years).
  • Conference Chair & Committee Member — 2nd Global Conference on Pain Research, 13th International Congress of Gynaecology and Obstetrics, multiple oncology & gene therapy congresses (2025–2026).
  • Mentoring — 4 PhD Internal Members & 4 Undergraduate Honors Thesis, University of Florida College of Medicine (2017–2024).
  • Invited Speaker & Reviewer — 30+ international conferences and top-tier journals (Gut IF 23.16, Cell Reports Medicine, Molecular Therapy, etc.).
Top